Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Hookipa Pharma Inc (HOOK)

Hookipa Pharma Inc (HOOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 79,764
  • Shares Outstanding, K 98,950
  • Annual Sales, $ 20,130 K
  • Annual Income, $ -81,580 K
  • 60-Month Beta 1.02
  • Price/Sales 4.18
  • Price/Cash Flow N/A
  • Price/Book 0.84
Trade HOOK with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.77
  • Most Recent Earnings $-0.11 on 03/22/24
  • Latest Earnings Date 05/09/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 347.00% ( +87.73%)
  • Historical Volatility 73.63%
  • IV Percentile 71%
  • IV Rank 28.80%
  • IV High 1,171.40% on 10/10/23
  • IV Low 13.49% on 02/09/24
  • Put/Call Vol Ratio 0.19
  • Today's Volume 636
  • Volume Avg (30-Day) 233
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 5,054
  • Open Int (30-Day) 3,724

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.12
  • Number of Estimates 2
  • High Estimate -0.05
  • Low Estimate -0.18
  • Prior Year -0.27
  • Growth Rate Est. (year over year) +55.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7000 +27.14%
on 04/22/24
0.9500 -6.32%
on 04/26/24
+0.1710 (+23.78%)
since 03/26/24
3-Month
0.5789 +53.74%
on 01/29/24
0.9500 -6.32%
on 04/26/24
+0.1892 (+27.00%)
since 01/26/24
52-Week
0.4100 +117.07%
on 10/26/23
2.0500 -56.59%
on 05/12/23
-0.1200 (-11.88%)
since 04/26/23

Most Recent Stories

More News
HOOKIPA Pharma Inc. (HOOK) Reports Q1 Loss, Lags Revenue Estimates

HOOKIPA Pharma Inc. (HOOK) delivered earnings and revenue surprises of -12.50% and 15.31%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

HOOK : 0.8900 (+10.41%)
CELU : 3.02 (-1.63%)
Mirati (MRTX) Reports Q1 Loss, Tops Revenue Estimates

Mirati (MRTX) delivered earnings and revenue surprises of 8.36% and 41.08%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

MRTX : 58.70 (-0.17%)
HOOK : 0.8900 (+10.41%)
HOOKIPA Pharma Inc. (HOOK) Reports Q4 Loss, Tops Revenue Estimates

HOOKIPA Pharma Inc. (HOOK) delivered earnings and revenue surprises of 5.56% and 41.25%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

HOOK : 0.8900 (+10.41%)
ADMA : 6.55 (+1.71%)
Avid Bioservices (CDMO) Q3 Earnings and Revenues Top Estimates

Avid Bioservices (CDMO) delivered earnings and revenue surprises of 275% and 5.61%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?

CDMO : 7.35 (+0.41%)
HOOK : 0.8900 (+10.41%)
Intercept Pharmaceuticals (ICPT) Reports Q4 Loss, Tops Revenue Estimates

Intercept (ICPT) delivered earnings and revenue surprises of 20.75% and 0.42%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

ICPT : 19.00 (+0.21%)
HOOK : 0.8900 (+10.41%)
HOOKIPA Pharma Inc. (HOOK) Reports Q3 Loss, Misses Revenue Estimates

HOOKIPA Pharma Inc. (HOOK) delivered earnings and revenue surprises of -4.17% and 31.49%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

HOOK : 0.8900 (+10.41%)
CDMO : 7.35 (+0.41%)
Werewolf Therapeutics, Inc. (HOWL) Reports Q3 Loss, Misses Revenue Estimates

Werewolf Therapeutics, Inc. (HOWL) delivered earnings and revenue surprises of 33.33% and 18.53%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the...

HOWL : 6.75 (+8.70%)
HOOK : 0.8900 (+10.41%)
AVEO Pharmaceuticals (AVEO) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

AVEO (AVEO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AVEO : 15.00 (unch)
HOOK : 0.8900 (+10.41%)
HOOKIPA Pharma Inc. (HOOK) Expected to Beat Earnings Estimates: Should You Buy?

HOOKIPA Pharma Inc. (HOOK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

HOOK : 0.8900 (+10.41%)
RVNC : 3.40 (+3.34%)
GSK Gears Up to Report Q3 Earnings: What's in the Cards?

Sales of GSK's vaccine segment, especially meningitis and influenza vaccines, are likely to have been an important contributor to third-quarter 2022 sales.

GSK : 41.11 (+0.49%)
ANGN : 10.0000 (+2.04%)
HOOK : 0.8900 (+10.41%)
VIR : 8.23 (+7.86%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

HOOKIPA Pharma Inc. is a clinical stage biopharmaceutical company. It is engaged in developing a class of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary arenavirus platform which is designed to reprogram the body's immune system. HOOKIPA Pharma Inc. is based in...

See More

Key Turning Points

3rd Resistance Point 0.9421
2nd Resistance Point 0.8924
1st Resistance Point 0.8493
Last Price 0.8900
1st Support Level 0.7565
2nd Support Level 0.7068
3rd Support Level 0.6637

See More

52-Week High 2.0500
Fibonacci 61.8% 1.4235
Fibonacci 50% 1.2300
Fibonacci 38.2% 1.0365
Last Price 0.8900
52-Week Low 0.4100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar